Jesús
García Mata
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (5)
2020
-
The economic burden of metastatic breast cancer in Spain
European Journal of Hospital Pharmacy , Vol. 27, Núm. 1, pp. 19-24
2009
-
Use of pegfilgrastim support on day 9 to maintain relative dose intensity of chemotherapy in breast cancer patients receiving a day 1 and 8 CMF regimen
Clinical and Translational Oncology, Vol. 11, Núm. 12, pp. 842-848
2007
-
Advanced breast cancer: Chemotherapy phase III trials that change a standard
Anti-Cancer Drugs
-
Evidence-based use of taxanes in the adjuvant setting of breast cancer. A review of randomized phase III trials
Cancer Treatment Reviews, Vol. 33, Núm. 5, pp. 474-483
-
The use of taxanes in the neoadjuvant treatment of breast cancer: A review of randomized phase II/III trials
Clinical Breast Cancer, Vol. 7, Núm. 10, pp. 764-774